Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216495 · ClinicalTrials.gov registry record · NA
Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC
A NA study of Aerobic Exercise and Early Stage Triple Negative Breast Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT07216495 is a NA study of Aerobic Exercise and Early Stage Triple Negative Breast Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 33 participants, below the 141-participant average among 3 other Aerobic Exercise trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07216495, a NA study of Aerobic Exercise and Early Stage Triple Negative Breast Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if participating in a supervised exercise program can help participants with early-stage TNBC who are receiving ICI therapy before undergoing breast surgery.
Conditions Studied
Interventions
- OTHER Exercise
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2030-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216495
The ClinicalTrials.gov registry entry for NCT07216495 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 3 other Aerobic Exercise trials with a reported enrollment target (77% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aerobic Exercise appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT07216495 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07216495 about?
NCT07216495 is a clinical study titled "Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC". To learn if participating in a supervised exercise program can help participants with early-stage TNBC who are receiving ICI therapy before undergoing breast surgery.
What is the current status of trial NCT07216495?
This trial is currently recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2026-02-23. Estimated completion is 2030-10-30.
What conditions does trial NCT07216495 study?
This clinical trial studies the following conditions: Aerobic Exercise, Early Stage Triple Negative Breast Cancer.
What interventions are being tested in trial NCT07216495?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT07216495?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216495 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aerobic Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.